Alcohol-Related Disorders Market Size to Reach USD 1770.7 Million by 2035, Impelled by Advancements in Pharmacological Therapies

March 19, 2025 | Chemical & Materials

VIEW FULL TABLE OF CONTENTS

Alcohol-Related Disorders Market Outlook 2025-2035:

The 7 major alcohol-related disorders market reached a value of USD 723.8 Million in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 1770.7 Million by 2035, exhibiting a growth rate (CAGR) of 8.47% during 2025-2035. The alcohol-related disorder treatment market is experiencing a significant shift fueled by the growing adoption of non-invasive and integrated treatment approaches. These methods, such as medication-assisted therapies (MAT) combined with behavioural therapies and delivered through increasingly accessible telemedicine platforms, represent a paradigm shift in how alcohol dependency is managed. By prioritizing less stigmatizing and more convenient pathways to care, these approaches are proving highly effective in addressing the complex challenges of alcohol related disorder. The benefits extend beyond mere symptom management; these integrated treatments are adept at curbing cravings, preventing the high risk of relapse, and simultaneously addressing co-occurring mental health conditions that often complicate recovery, leading to improved patient outcomes and increased satisfaction. The move away from traditional, often lengthy and invasive interventions, like prolonged inpatient stays, highlights a preference for efficient, accessible solutions, positioning these modern therapies as the future of alcohol-related disorder treatment.

Alcohol-Related Disorders Market Outlook

To get more information on this market, Request Sample

Advancements in Pharmacological Therapies Drive Growth in Alcohol-Related Disorder Treatment

The expanding arsenal of pharmacological therapies stands as one of the stronger forces driving this growth. Pharmacological agents that include naltrexone, acamprosate, and disulfiram revolutionized alcohol-dependence treatment and management through precise and targeted efforts. These pharmacological agents focus on multiplanar complexity of alcohol-related disorder, working to both reduce craving as well as moderate the often-severely debilitating signs of withdrawal. Naltrexone, for example, reverses the pleasurable effects of alcohol, enabling patients to take back control over their drinking behavior. Acamprosate is targeted at re-establishing the neurochemical imbalances induced by chronic alcohol consumption, while disulfiram is a strong aversive agent that produces an unpleasant physical response when alcohol is ingested. Most of the applications of such medications are in their combination with behavioral therapies, thus creating a synergistic effect that positively impacts the treatment process. Research is currently ongoing to drive innovation in the development of next-generation drugs with improved patient adherence and fewer adverse side effects. The integration of these pharmacological treatments with telemedicine platforms is also proving transformative, expanding access to care in previously underserved and remote communities. These advancements are collectively reshaping the field of AUD treatment, offering hope and improved long-term recovery outcomes for those struggling with alcohol dependence.

Innovative Therapies and Advanced Drug Delivery Transform the Alcohol-related Disorder Treatment Landscape

The treatment landscape for alcohol-related disorders is witnessing great advancements, driven by the emergence of innovative therapies and sophisticated pharmacological strategies. Novel oral and injectable medications are being developed, which are specifically designed to directly target the neurochemical imbalances and intense cravings that define Alcohol-Related Disorder. These innovative agents have shown promising efficacy, less toxicity, and enhanced patient compliance that will all together help achieve better outcomes in the treatment. Biological treatments are also increasingly becoming important for individuals with moderate to severe AUD, and also those suffering from chronic or relapsing patterns. Latest research explores the use of monoclonal antibodies that selectively target key neurotransmitter systems, in this case GABA and glutamate, to directly modulate the brain's reward pathways and reduce alcohol dependence. Improved drug delivery technologies, including extended-release injectable formulations and transdermal patches, also open the way for consistent therapeutic drug levels with consequent minimization of adverse effects and enhancement of long-term treatment adherence. These advances, however, are intertwined to give the picture of a quickly changing and inclusive approach to treating alcohol-related disorders, with new hope avenues for the more effective and sustainable recovery of individuals.

Marketed Therapies in Alcohol-related Disorder Market

Vivitrol (Naltrexone controlled-release) – Alkermes

Vivitrol, the brand name for naltrexone sustained-release injection, stands as a significant tool in the fight against Alcohol-Related Disorder. Approved by the FDA, this medication offers a unique approach to treatment, operating on the neurological level to help individuals manage their cravings and reduce the compulsion to drink.

Campral (Acamprosate calcium) - Forest Pharmaceuticals

Campral, the brand name for acamprosate calcium, is a medication approved by the FDA for the treatment of alcohol-related disorder. Its primary role is to assist individuals in maintaining sobriety after they have stopped drinking, rather than helping them to initially detox.

Emerging Therapies in Alcohol-Related Disorder Market

Psilocybin - Clairvoyant Therapeutics

Psilocybin, a naturally occurring psychedelic compound found in certain mushrooms, is emerging as a promising therapeutic agent in the fight against alcohol-related disorder. Recent clinical studies have begun to illuminate the potential of this substance to disrupt the entrenched patterns of addiction.

BPL-003 - Beckley Psytech Limited

BPL-003 represents a novel approach in the treatment of alcohol-related disorder, moving beyond traditional methods by directly targeting the neurological underpinnings of addiction. This investigational drug is designed to interact with specific pathways in the brain that are known to contribute to alcohol cravings and compulsive drinking behaviours.

ASP8062 - Astellas Pharma

ASP8062, an investigational drug from Astellas Pharma, represents a promising avenue in the ongoing fight against alcohol-related disorder. This compound is not a simple deterrent; rather, it is being developed with a sophisticated understanding of the neurobiological complexities underpinning alcohol dependence.

Drug Name	Company Name	MOA	ROA
Psilocybin	Clairvoyant Therapeutics	ATP-binding cassette transporter modulator	Oral
BPL-003	Beckley Psytech Limited	Serotonin receptor modulators	Intranasal
ASP8062	Astellas Pharma	GABA B receptor modulators	Oral

Detailed list of emerging therapies in alcohol-related disorder is provided in the final report…

Leading Companies In The Alcohol-Related Disorder Market:

These key players are not only developing individual therapies but are also heavily investing in integrated solutions that aim to improve the comprehensive management of ARD. Companies like Alkermes, Forest Pharmaceuticals, Clairvoyant Therapeutics, Beckley Psytech Limited, and Astellas Pharma, among others, are at the forefront of this innovation, pushing the boundaries of treatment options. Their efforts encompass a broad spectrum, from pioneering novel pharmacological therapies and exploring cutting-edge biologic treatments to expanding their portfolios to include a diverse range of options catering to varying patient needs. This dedication to research and development is critical for the industry as these companies strive to meet the escalating demand for effective addiction treatments. The focus on enhanced diagnostic tools and the exploration of combination therapies underscores their commitment to providing more personalized and effective care, ultimately aiming to improve outcomes for individuals battling alcohol addiction. Therefore, this commitment to innovation and tailored care is a crucial development in the market, reflecting a growing understanding of the complexities of ARD and the need for multifaceted treatment approaches.

In April 2024, Clairvoyant Therapeutics a dedicated clinical-stage pharmaceutical company, is making significant strides in the realm of psychedelic medicine. Focusing on the therapeutic potential of psilocybin, they are specifically targeting alcohol-related disorder (ARD), a condition affecting millions worldwide.

Key Players in Alcohol-Related Disorder Market:

The key players in the alcohol-related disorder market who are in different phases of developing different therapies are Alkermes, Forest Pharmaceuticals, Clairvoyant Therapeutics, Beckley Psytech Limited, Astellas Pharma, and Others.

Key Players in Alcohol-Related Disorder Market

Regional Analysis:

The market for alcohol-related disorder (ARD) treatment is significant, with major players located in regions such as the United States, Germany, France, the United Kingdom, Italy, Spain, and Japan. The United States, in particular, stands out with the largest patient population and the largest market share for ARD treatment, a trend expected to persist, according to IMARC. This growing market is fueled by recent advancements in treatment methods, which are moving beyond traditional approaches to adopt more innovative solutions.

Medication-Assisted Treatment (MAT), monoclonal antibodies, and neurobiological therapies lead the way for more effective treatments of ARD symptoms. It has expanded beyond personalized and holistic treatment strategies that involve novel drugs aimed at correcting neurochemical imbalances coupled with comprehensive behavioral therapies. Such a combination is meant to diminish alcohol cravings and improve long-term recovery outcomes in addition to targeting the prevalent comorbidity of mental health disorders to provide a better-rounded approach to intervention.

Advancements in diagnostic tools and screening technology are enabling the early detection and accurate identification of potential individuals with ARD. This would stop the accelerating step of alcohol dependency and minimize its harmful effects on the organism. The main driving forces of market growth are regulatory approvals, growing research and development investments, and strengthened partnerships between pharmaceutical companies, diagnostic technology providers, and research facilities. These factors are poised to accelerate the availability of more effective treatments and diagnostic solutions for individuals struggling with alcohol-related disorders.

Recent Developments in Alcohol-Related Disorder Market:

In March 2024, Clerkenwell Health, a rising force in modern mental healthcare, has unveiled a significant partnership with Beckley Psytech, a pioneering biotechnology firm focused on psychedelic medicines. This collaboration marks the commencement of a Phase IIa clinical trial, a critical step in investigating a novel approach to treating alcohol-related disorder.
In April 2024, Clairvoyant Therapeutics a dedicated clinical-stage pharmaceutical company, is making significant strides in the realm of psychedelic medicine. Focusing on the therapeutic potential of psilocybin, they are specifically targeting alcohol-related disorder, a condition affecting millions worldwide.

Key information covered in the report

Base Year: 2024
Historical Period: 2019-2024
Market Forecast: 2025-2035

Countries Covered

United States
Germany
France
United Kingdom
Italy
Spain
Japan

 Analysis Covered Across Each Country

Historical, current, and future epidemiology scenario
Historical, current, and future performance of the alcohol-related disorder market
Historical, current, and future performance of various therapeutic categories in the market
Sales of various drugs across the alcohol-related disordermarket
Reimbursement scenario in the market
In-market and pipeline drugs

Competitive Landscape:

This report offers a comprehensive analysis of current alcohol-related disorder marketed drugs and late-stage pipeline drugs.

In-Market Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

 Late-Stage Pipeline Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. Across the six major continents and 100+ countries, we work alongside our business partners as one team with a common ambition to achieve unparallelled results, gain a competitive edge, and transform industries. IMARC Group excels in understanding its clients’ business priorities and delivering tailored solutions that drive meaningful outcomes. Our client base spans over 3,000 organizations in the private, public, and social sectors, ranging from high-growth startups to Fortune 500 companies.

Contact Us:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Phone Number: - +1 631 791 1145, +91-120-433-0800

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Alcohol-Related Disorders Market Size to Reach USD 1770.7 Million by 2035, Impelled by Advancements in Pharmacological Therapies

Purchase Options Discount
Offer

Inquire Before Buying

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.